1921
Volume 86, Issue 5
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

T regulatory cells (Tregs) play an important role in the mechanism of host's failure to control pathogen dissemination in severe forms of different chronic granulomatous diseases, but their role in leprosy has not yet been elucidated; 28 newly diagnosed patients (16 patients with lepromatous leprosy and 12 patients with tuberculoid leprosy) and 6 healthy -exposed individuals (contacts) were studied. Tregs were quantified by flow cytometry (CD4+ CD25+ Foxp3+) in peripheral blood mononuclear cells stimulated with a antigenic preparation and phytohemagglutinin as well as in skin lesions by immunohistochemistry. The lymphoproliferative (LPR), interleukin-10 (IL-10), and interferon-γ (IFN-γ) responses of the -stimulated peripheral blood mononuclear cells and the expression of IL-10, transforming growth factor-β (TGF-β), and cytotoxic T-lymphocyte antigen 4 (CTLA-4) were also determined. We show that antigens induced significantly lower LPR but significantly higher Treg numbers in lepromatous than tuberculoid patients and contacts. Mitogen-induced LPR and Treg frequencies were not significantly different among the three groups. Tregs were also more frequent in lepromatous patients, and this finding was paralleled by increased expression of the antiinflammatory molecules IL-10 and CTLA-4 but not TGF-β. In lepromatous patients, Tregs were intermingled with vacuolized hystiocyte infiltrates all over the lesion, whereas in tuberculoid patients, Tregs were rare. Our results suggest that Tregs are present in increased numbers, and they may have a pathogenic role in leprosy patients harboring uncontrolled bacillary multiplication but not in those individuals capable of limiting growth.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.2012.12-0088
2012-05-01
2017-09-25
Loading full text...

Full text loading...

/deliver/fulltext/14761645/86/5/878.html?itemId=/content/journals/10.4269/ajtmh.2012.12-0088&mimeType=html&fmt=ahah

References

  1. Ridley DS, Jopling WH, , 1966. Classification of leprosy according to immunity: a five-group system. Int J Lepr 34: 255273.
  2. Montoya D, Modlin RL, , 2010. Learning from leprosy: insight into the human innate immune response. Adv Immunol 105: 124.[Crossref]
  3. Modlin RL, Mehra V, Wong L, Fujimiya Y, Chang WC, Horwitz DA, Bloom BR, Rea TH, Pattengale PK, , 1986. Suppressor T lymphocytes from lepromatous leprosy skin lesions. J Immunol 137: 28312834.
  4. Sakaguchi S, Miyara M, Costantino CM, Hafler DA, , 2010. FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol 10: 490500.[Crossref]
  5. Shevach EM, , 2009. Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity 30: 636645.[Crossref]
  6. Kuhn A, Beissert S, Krammer PH, , 2009. CD4(+)CD25 (+) regulatory T cells in human lupus erythematosus. Arch Dermatol Res 301: 7181.[Crossref]
  7. Antiga E, Quaglino P, Bellandi S, Volpi W, Del Bianco E, Comessatti A, Osella-Abate S, De Simone C, Marzano A, Bernengo MG, Fabbri P, Caproni M, , 2010. Regulatory T cells in the skin lesions and blood of patients with systemic sclerosis and morphoea. Br J Dermatol 162: 10561063.[Crossref]
  8. Engler JB, Undeutsch R, Kloke L, Rosenberger S, Backhaus M, Schneider U, Egerer K, Dragun D, Hofmann J, Huscher D, Burmester GR, Humrich JY, Enghard P, Riemekasten G, , 2011. Unmasking of autoreactive CD4 T cells by depletion of CD25 regulatory T cells in systemic lupus erythematosus. Ann Rheum Dis 70: 21762183.[Crossref]
  9. Guyot-Rovol V, Innes JA, Hackforth S, , 2006. Regulatory T cells are expanded in blood and disease sites in tuberculosis patients. Am J Respir Crit Care Med 173: 803810.[Crossref]
  10. Campanelli AP, Roselino AM, Cavassani KA, Pereira MSF, Mortara RA, Brodskyn CI, Goncalves HS, Belkaid Y, Barral-Netto M, Barral A, Silva JS, , 2006. CD4+CD25+ T cells in skin lesions of patients with cutaneous leishmaniasis exhibit phenotypic and functional characteristics of natural regulatory T cells. J Infect Dis 193: 13131322.[Crossref]
  11. Silva LC, Silveira GG, Arnone M, Romiti R, Geluk A, Franken KC, Duarte AJ, Takahashi MD, Benard G, , 2010. Decrease in Mycobacterium tuberculosis specific immune responses in patients with untreated psoriasis living in a tuberculosis endemic area. Arch Dermatol Res 302: 255262.[Crossref]
  12. Cavassani KA, Campanelli AP, Moreira AP, Vancim JO, Vitali LH, Mamede RC, Martinez R, Silva JS, , 2006. Systemic and local characterization of regulatory T cells in a chronic fungal infection in humans. J Immunol 177: 58115818.[Crossref]
  13. Herzenberg LA, Tung J, Moore WA, Herzenberg LA, Parks DR, , 2006. Interpreting flow cytometry data: a guide for the perplexed. Nat Immunol 7: 681685.[Crossref]
  14. Pagliari C, Fernandes ER, Stegun FW, da Silva WL, Duarte MIS, Sotto MN, , 2011. Paracoccidioidomycosis: cells expressing IL17 and Foxp3 in cutaneous and mucosal lesions. Microb Pathog 50: 263267.[Crossref]
  15. Baecher-Allan C, Hafler DA, , 2004. Suppressor T cells in human diseases. J Exp Med 200: 273276.[Crossref]
  16. Belkaid Y, Piccirillo CA, Mendez S, Shevach EM, Sacks DL, , 2002. Role for CD4(+) CD25(+) regulatory T cells in reactivation of persistent leishmaniasis and control of concomitant immunity. Nature 420: 502507.[Crossref]
  17. Bourreau E, Ronet C, Darcissac E, Lise MC, Sainte Marie D, Clity E, Tacchini-Cottier F, Couppie P, Launois P, , 2009. Intralesional regulatory T-cell suppressive function during human acute and chronic cutaneous leishmaniasis due to Leishmania guyanensis . Infect Immun 77: 14651474.[Crossref]
  18. Maurya R, Kumar R, Prajapati VK, Manandhar KD, Sacks D, Sundar S, Nylén S, , 2010. Human visceral leishmaniasis is not associated with expansion or accumulation of Foxp3+ CD4 cells in blood or spleen. Parasite Immunol 32: 479483.[Crossref]
  19. Katara GK, Ansari NA, Verma S, Ramesh V, Salotra P, , 2011. Foxp3 and IL-10 expression correlates with parasite burden in lesional tissues of post kala azar dermal leishmaniasis (PKDL) patients. PLoS Negl Trop Dis 5: e1171.[Crossref]
  20. Ismail A, Gadir AF, Theander TG, Kharazmi A, El Hassan AM, , 2006. Pathology of post-kala-azar dermal leishmaniasis: a light microscopical, immunohistochemical, and ultrastructural study of skin lesions and draining lymph nodes. J Cutan Pathol 33: 778787.[Crossref]
  21. Attia EA, Abdallah M, Saad AA, Afifi A, El Tabbakh A, El-Shennawy D, Ali HB, , 2010. Circulating CD4+ CD25 high FoxP3+T cells vary in different clinical forms of leprosy. Int J Dermatol 49: 11521158.[Crossref]
  22. Massone C, Nunzi E, Ribeiro-Rodrigues R, Talhari C, Talhari S, Schettini AP, Parente JN, Brunasso AM, Puntoni M, Clapasson A, Noto S, Cerroni L, , 2010. T regulatory cells and plasmocytoid dendritic cells in Hansen disease: a new insight into pathogenesis? Am J Dermatopathol 32: 251256.[Crossref]
  23. Epple HJ, Loddenkemper C, Kunkel D, Tröger H, Maul J, Moos V, Berg E, Ullrich R, Schulzke JD, Stein H, Duchmann R, Zeitz M, Schneider T, , 2006. Mucosal but not peripheral FOXP3+ regulatory T cells are highly increased in untreated HIV infection and normalize after suppressive HAART. Blood 108: 30723078.[Crossref]
  24. Longley J, Haregewoin A, Yemaneberhan T, Warndorff van Diepen T, Nsibami J, Knowles D, Smith KA, Godal T, , 1985. In vivo responses to Mycobacterium leprae: antigen presentation, interleukin-2 production, and immune cell phenotypes in naturally occurring leprosy lesions. Int J Lepr Other Mycobact Dis 53: 385394.
  25. Haregewoin A, Longley J, Bjune G, Mustafa AS, Godal T, , 1985. The role of interleukin-2 (IL-2) in the specific unresponsiveness of lepromatous leprosy to Mycobacterium leprae: studies in vitro and in vivo . Immunol Lett 11: 249252.[Crossref]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.2012.12-0088
Loading
/content/journals/10.4269/ajtmh.2012.12-0088
Loading

Data & Media loading...

  • Received : 07 Feb 2012
  • Accepted : 14 Feb 2012

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error